These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer. Heckmann D, Maier P, Laufs S, Li L, Sleeman JP, Trunk MJ, Leupold JH, Wenz F, Zeller WJ, Fruehauf S, Allgayer H. Clin Cancer Res; 2014 Feb 01; 20(3):604-16. PubMed ID: 24255072 [Abstract] [Full Text] [Related]
23. CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Juarez J, Dela Pena A, Baraz R, Hewson J, Khoo M, Cisterne A, Fricker S, Fujii N, Bradstock KF, Bendall LJ. Leukemia; 2007 Jun 01; 21(6):1249-57. PubMed ID: 17410186 [Abstract] [Full Text] [Related]
24. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L. Haematologica; 2012 Apr 01; 97(4):608-15. PubMed ID: 22058221 [Abstract] [Full Text] [Related]
28. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ. Leukemia; 2000 May 01; 14(5):882-8. PubMed ID: 10803521 [Abstract] [Full Text] [Related]
29. Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. Goodrich AD, Varain NM, Jeanblanc CM, Colon DM, Kim J, Zanjani ED, Hematti P. Cytotherapy; 2014 Sep 01; 16(9):1280-93. PubMed ID: 25108653 [Abstract] [Full Text] [Related]
30. Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells. Hira VV, Verbovšek U, Breznik B, Srdič M, Novinec M, Kakar H, Wormer J, der Swaan BV, Lenarčič B, Juliano L, Mehta S, Van Noorden CJ, Lah TT. Biochim Biophys Acta Mol Cell Res; 2017 Mar 01; 1864(3):594-603. PubMed ID: 28040478 [Abstract] [Full Text] [Related]
31. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM. Neoplasia; 2012 Aug 01; 14(8):709-18. PubMed ID: 22952424 [Abstract] [Full Text] [Related]
32. Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis. Li X, Guo H, Duan H, Yang Y, Meng J, Liu J, Wang C, Xu H. Sci Rep; 2015 Nov 05; 5():16228. PubMed ID: 26538086 [Abstract] [Full Text] [Related]
33. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies. Peled A, Klein S, Beider K, Burger JA, Abraham M. Cytokine; 2018 Sep 05; 109():11-16. PubMed ID: 29903571 [Abstract] [Full Text] [Related]
39. Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial remodeling. Song B, Chen D, Liu Z, Cheng Y, Zhang Z, Han W, Zhang R, Gong Y. Biochem Biophys Res Commun; 2022 Feb 26; 594():38-45. PubMed ID: 35066378 [Abstract] [Full Text] [Related]